Physician profile
Desiree Hopping
NPI 1376697292
$883.95
in general payments reported to CMS, 2019-2025
12 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Pediatrics (Optometrist) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $16.69 · 2022: $285 · 2023: $65.70 · 2024: $227 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Entertainment: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.46 |
| Entertainment | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $199.18 | 2022-2025 | Miebo, Infuse |
| Alcon Vision LLC | $176.15 | 2019-2025 | Dailies Total1, Precision7 |
| Abbvie INC. | $107.62 | 2022-2023 | |
| Glaukos Corporation | $81.41 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Coopervision INC. | $71.59 | 2022-2023 | Myday Contact Lens |
| Maculogix, INC. | $61.02 | 2019 | |
| Biotissue Holdings INC. | $40.67 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.26 | 2019 | |
| Optos, INC. | $35.00 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $31.14 | 2020-2024 | Tearcare System |
| Allergan, INC. | $22.64 | 2022 | |
| Oyster Point Pharma, INC. | $21.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Hopping listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.